EU ‘negotiating with Valneva’ over COVID-19 vaccine contract
pharmaphorum
SEPTEMBER 15, 2021
The European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to supply COVID-19 vaccines that was terminated by the UK government this week. A French government source told Reuters that the EU is considering using the VLA2001 vaccine as part of its booster campaign plans, along with a shot from Sanofi and GlaxoSmithKline.
Let's personalize your content